Plunkett Research Online: Liminal BioSciences Inc

LIMINAL BIOSCIENCES INC (LMNL:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Liminal Biosciences Inc is a clinical stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using our drug discovery platform and a data driven approach. The company has active business operations in Can.....



Liminal BioSciences Inc
Ticker: LMNL
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 450 781-0115
Fax: 450 781-4477
Address: 231 Dundas Street East
Suite 300
Belleville, ON K8N 1E2 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Plasma Technologies
Clinical-Stage Biopharmaceuticals
Drug Discovery
Drug Development
Contacts Description
Bruce Pritchard CEO
Nicole Rusaw-George CFO
See More
Liminal Biosciences Inc is a clinical stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using our drug discovery platform and a data driven approach. The company has active business operations in Can.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Fezagepras
Ryplazim
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: